Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)

Pathological angiogenesis is the hallmark of ischemic retinal diseases among them retinopathy of prematurity (ROP) and proliferative diabetic retinopathy (PDR). Oxygen-induced retinopathy (OIR) is a pure hypoxia-driven angiogenesis model and a widely used model for ischemic retinopathies. We explore...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Vähätupa, Niklas Salonen, Hannele Uusitalo-Järvinen, Tero A. H. Järvinen
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/11890a4f002747f4986ce99736e5812f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11890a4f002747f4986ce99736e5812f
record_format dspace
spelling oai:doaj.org-article:11890a4f002747f4986ce99736e5812f2021-11-25T18:42:03ZSelective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)10.3390/pharmaceutics131119321999-4923https://doaj.org/article/11890a4f002747f4986ce99736e5812f2021-11-01T00:00:00Zhttps://www.mdpi.com/1999-4923/13/11/1932https://doaj.org/toc/1999-4923Pathological angiogenesis is the hallmark of ischemic retinal diseases among them retinopathy of prematurity (ROP) and proliferative diabetic retinopathy (PDR). Oxygen-induced retinopathy (OIR) is a pure hypoxia-driven angiogenesis model and a widely used model for ischemic retinopathies. We explored whether the vascular homing peptide CAR (CARSKNKDC) which recognizes angiogenic blood vessels can be used to target the retina in OIR. We were able to demonstrate that the systemically administered CAR vascular homing peptide homed selectively to the preretinal neovessels in OIR. As a cell and tissue-penetrating peptide, CAR also penetrated into the retina. Hyperoxia used to induce OIR in the retina also causes bronchopulmonary dysplasia in the lungs. We showed that the CAR peptide is not targeted to the lungs in normal mice but is targeted to the lungs after hyperoxia-/hypoxia-treatment of the animals. The site-specific delivery of the CAR peptide to the pathologic retinal vasculature and the penetration of the retinal tissue may offer new opportunities for treating retinopathies more selectively and with less side effects.Maria VähätupaNiklas SalonenHannele Uusitalo-JärvinenTero A. H. JärvinenMDPI AGarticlevascular homing peptidecell penetrating peptideangiogenesisoxygen-induced retinopathy (OIR)retinadiabetic retinopathyPharmacy and materia medicaRS1-441ENPharmaceutics, Vol 13, Iss 1932, p 1932 (2021)
institution DOAJ
collection DOAJ
language EN
topic vascular homing peptide
cell penetrating peptide
angiogenesis
oxygen-induced retinopathy (OIR)
retina
diabetic retinopathy
Pharmacy and materia medica
RS1-441
spellingShingle vascular homing peptide
cell penetrating peptide
angiogenesis
oxygen-induced retinopathy (OIR)
retina
diabetic retinopathy
Pharmacy and materia medica
RS1-441
Maria Vähätupa
Niklas Salonen
Hannele Uusitalo-Järvinen
Tero A. H. Järvinen
Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
description Pathological angiogenesis is the hallmark of ischemic retinal diseases among them retinopathy of prematurity (ROP) and proliferative diabetic retinopathy (PDR). Oxygen-induced retinopathy (OIR) is a pure hypoxia-driven angiogenesis model and a widely used model for ischemic retinopathies. We explored whether the vascular homing peptide CAR (CARSKNKDC) which recognizes angiogenic blood vessels can be used to target the retina in OIR. We were able to demonstrate that the systemically administered CAR vascular homing peptide homed selectively to the preretinal neovessels in OIR. As a cell and tissue-penetrating peptide, CAR also penetrated into the retina. Hyperoxia used to induce OIR in the retina also causes bronchopulmonary dysplasia in the lungs. We showed that the CAR peptide is not targeted to the lungs in normal mice but is targeted to the lungs after hyperoxia-/hypoxia-treatment of the animals. The site-specific delivery of the CAR peptide to the pathologic retinal vasculature and the penetration of the retinal tissue may offer new opportunities for treating retinopathies more selectively and with less side effects.
format article
author Maria Vähätupa
Niklas Salonen
Hannele Uusitalo-Järvinen
Tero A. H. Järvinen
author_facet Maria Vähätupa
Niklas Salonen
Hannele Uusitalo-Järvinen
Tero A. H. Järvinen
author_sort Maria Vähätupa
title Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
title_short Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
title_full Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
title_fullStr Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
title_full_unstemmed Selective Targeting and Tissue Penetration to the Retina by a Systemically Administered Vascular Homing Peptide in Oxygen Induced Retinopathy (OIR)
title_sort selective targeting and tissue penetration to the retina by a systemically administered vascular homing peptide in oxygen induced retinopathy (oir)
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/11890a4f002747f4986ce99736e5812f
work_keys_str_mv AT mariavahatupa selectivetargetingandtissuepenetrationtotheretinabyasystemicallyadministeredvascularhomingpeptideinoxygeninducedretinopathyoir
AT niklassalonen selectivetargetingandtissuepenetrationtotheretinabyasystemicallyadministeredvascularhomingpeptideinoxygeninducedretinopathyoir
AT hanneleuusitalojarvinen selectivetargetingandtissuepenetrationtotheretinabyasystemicallyadministeredvascularhomingpeptideinoxygeninducedretinopathyoir
AT teroahjarvinen selectivetargetingandtissuepenetrationtotheretinabyasystemicallyadministeredvascularhomingpeptideinoxygeninducedretinopathyoir
_version_ 1718410756827906048